Sponsor

CRISPR Therapeutics AG

Baarerstrasse 14, 6300

About the sponsor

Clinical research includes hematologic malignancies and solid malignancies, with attention to long-term outcomes after CAR cellular therapy for cancer.

Hematologic malignancy
Solid malignancy
CAR cellular therapy

These studies focus on malignant disease settings where engineered cell therapies are being evaluated for durable therapeutic activity.

About Specializations

CRISPR Therapeutics AG runs clinical trials in conditions such as Haematological malignancy, among others.

Haematological malignancy

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

1 clinical trial

Haematological malignancy

Recruiting

InvestigationalNo placebo

Long-term Safety Study of CRISPR CAR T Cell Therapy for Patients with Blood and Solid Cancers

InvestigationalNo placebo

Germany

Participants:18–64 years · 65+ years
Substances:Allogeneic Crispr/Cas9-Mediated Genetically Modified Car T Cells Targeting Cd19 Antigen
Sponsor:CRISPR Therapeutics AG

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →